Patent · US Active

Cancer therapy

US8765729B2 · kind B2 · utility

2Cited by
76References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 9, 2006
Grant dateJul 1, 2014
Priority date
Expiry dateOct 27, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P39/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates, in general, to cancer therapy, and, in particular, to a method of preventing or treating cancer using low molecular weight antioxidants (e.g., mimetics of superoxide dismutase (SOD)) as the active agent or as a chemo- and/or radio-protectant. The invention also relates to compounds and compositions suitable for use in such a method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.